(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Grasping the Elements of Medical caretaker Pay rates: Factors That Shape Your Pay17.10.2023 - 210 times the sky amazed us in 202522.12.2025
- 3Instructions to Utilize Your Brain science Certification to Work on Corporate Culture17.10.2023
- 46 US States for Fly Fishing01.01.1
- 5The most effective method to Apply Antiquated Ways of thinking in Current Brain science Practices17.10.2023
- 7 Methods for further developing Rest Quality
- One perk to marrying Richard Marx later in life? 'We don't have time' for stupid arguments, says Daisy Fuentes.
- Watch SpaceX launch powerful ocean-mapping satellite for Europe and NASA early Nov. 17
- Europe pledges over €15bn for clean energy for Africa
- Solar storms have influenced our history – an environmental historian explains how they could also threaten our future
- RFK Jr. guts the US childhood vaccine schedule despite its decades-long safety record
- Get To Be familiar with The Historical backdrop Of Western Medication
- The most effective method to Shake Hands During a Pandemic: Wellbeing Tips and Behavior
- Nuno Loureiro, MIT physicist, fatally shot at home; police investigate
